Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Mar 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 2641597010 | Rosiglitazone 4mg/glimepiride 4mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 2645703014 | Rosiglitazone 4mg/glimepiride 4mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 3471182016 | Product containing rosiglitazone 4 mg and glimepiride 4 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3487302012 | Product containing rosiglitazone 4 mg and glimepiride 4 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3502129010 | Rosiglitazone 4 mg and glimepiride 4 mg oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3570456017 | Product containing only rosiglitazone 4 mg and glimepiride 4 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3570457014 | Product containing only rosiglitazone 4 mg and glimepiride 4 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3682834013 | Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3682835014 | Glimepiride 4 mg and rosiglitazone maleate 4 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module | 
| 3682836010 | Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module | 
| 108430201000001112 | Rosiglitazone 4 mg and glimepiride 4 mg oral tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module | 
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Is a | Product containing glimepiride and rosiglitazone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has active ingredient | Rosiglitazone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has active ingredient | Glimepiride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has active ingredient | Rosiglitazone maleate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has active ingredient | Glimepiride | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has basis of strength substance | Glimepiride | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 4 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has active ingredient | Rosiglitazone maleate | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has basis of strength substance | Rosiglitazone maleate | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 4 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has precise active ingredient | Glimepiride | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has precise active ingredient | Rosiglitazone maleate | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Is a | Product containing glimepiride and rosiglitazone in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Is a | Product containing only glimepiride and rosiglitazone in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has precise active ingredient | Rosiglitazone maleate | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has basis of strength substance | Rosiglitazone maleate | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has precise active ingredient | Glimepiride | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet | Has basis of strength substance | Glimepiride | false | Inferred relationship | Existential restriction modifier | 2 | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
This concept is not in any reference sets